Cibc World Markets Corp Sells 115,496 Shares of Danaher Co. (NYSE:DHR)

Cibc World Markets Corp lessened its stake in shares of Danaher Co. (NYSE:DHR) by 41.7% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 161,353 shares of the conglomerate’s stock after selling 115,496 shares during the period. Cibc World Markets Corp’s holdings in Danaher were worth $37,039,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Heck Capital Advisors LLC bought a new position in shares of Danaher during the 4th quarter valued at approximately $27,000. Decker Retirement Planning Inc. purchased a new stake in Danaher in the 4th quarter worth approximately $31,000. Golden State Wealth Management LLC purchased a new stake in shares of Danaher in the fourth quarter worth $31,000. Teachers Insurance & Annuity Association of America purchased a new stake in shares of Danaher in the third quarter worth $39,000. Finally, MidAtlantic Capital Management Inc. purchased a new stake in shares of Danaher in the third quarter worth $40,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of analyst reports. Raymond James reiterated a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. Stifel Nicolaus upgraded Danaher from a “hold” rating to a “buy” rating and set a $260.00 target price for the company in a research report on Friday. Scotiabank started coverage on shares of Danaher in a report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price objective for the company. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective for the company in a report on Friday, December 13th. Finally, JPMorgan Chase & Co. cut their target price on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Six research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $277.76.

Insider Activity at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 11.10% of the stock is currently owned by corporate insiders.

Danaher Stock Up 3.4 %

NYSE:DHR opened at $211.09 on Monday. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70. The company has a market cap of $150.87 billion, a price-to-earnings ratio of 39.98, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The stock has a fifty day simple moving average of $220.07 and a 200-day simple moving average of $240.45. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the business posted $2.09 earnings per share. Analysts anticipate that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a $0.32 dividend. This is an increase from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.61%. The ex-dividend date is Friday, March 28th. Danaher’s payout ratio is presently 24.24%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.